TOI
HealthcareThe Oncology Institute, Inc.
$3.92
+$0.25 (+6.81%)
Jan 5, 2026
Price History (1Y)
Analysis
The Oncology Institute, Inc. (TOI) operates in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $385.65M, the company has a relatively significant scale compared to its peers. Its revenue for the trailing twelve months (TTM) stands at $461.04M, and it employs 825 individuals. Financially, TOI reports negative profitability metrics. The gross margin is 14.8%, while the operating margin and profit margin are -5.9% and -14.4%, respectively. Returns on equity and assets are also negative, at -4132.2% and -15.0%, respectively. The company's balance sheet shows a cash position of $27.66M and debt of $103.62M. The valuation metrics for TOI indicate a complex picture. With a forward P/E ratio of -24.50 and an EV/EBITDA ratio of -12.82, the company appears to be experiencing significant challenges. The price-to-book ratio is also negative at -31.11. However, the revenue growth rate has been substantial, with a year-over-year (YoY) increase of 36.7%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About The Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Visit website →Key Statistics
- Market Cap
- $385.65M
- P/E Ratio
- N/A
- 52-Week High
- $4.88
- 52-Week Low
- $0.25
- Avg Volume
- 2.21M
- Beta
- 0.18
Company Info
- Industry
- Medical Care Facilities
- Exchange
- NCM
- Country
- United States
- Employees
- 825